This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Human immunodeficiency virus [HIV] disease
AB1_HIV
AIDS: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
715 |
4. Check minimum number of eventsNone |
715 |
5. Include endpoints |
715 |
6. Filter based on genotype QC (FinnGen only) |
715 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
- Human immunodeficiency virus [HIV] disease resulting in other conditions
- Unspecified human immunodeficiency virus [HIV] disease
- Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
- Human immunodeficiency virus [HIV] disease resulting in other specified diseases
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 715 | 172 | 543 |
| Unadjusted period prevalence (%) | 0.20 | 0.06 | 0.24 |
| Median age at first event (years) | 38.64 | 37.11 | 39.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 650
- Matched controls
- 6499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
323.0
339
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
323.0
572
*
WW200
NOMESCO Finland
Immunization
277.6
323.0
502
78
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
33.4
264.9
370
247
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
233.9
210
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
178.6
163
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
21.6
130.6
200
131
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
11.3
105.1
218
278
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
76.6
72
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
166.6
71.6
74
5
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
64.7
61
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
51.2
353
1612
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.2
47.4
123
203
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
247.0
45.6
46
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
72.1
41.6
47
7
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
6.3
39.4
112
207
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
37.9
36
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
130.5
35.1
37
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.2
34.9
81
111
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
12.4
32.3
59
52
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
+∞
31.5
30
*
A53.9
ICD-10 Finland
Syphilis, unspecified
168.0
31.0
32
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
13.6
30.9
54
43
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
13.4
29.6
52
42
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
29.4
28
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.5
29.0
112
289
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.8
23.9
184
800
F43.29
ICD-10 Finland
Adaptation disorder UNS
10.7
23.7
46
46
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.9
23.3
171
722
WYA30
SPAT
NA
31.4
23.0
30
10
ULA02
NOMESCO Finland
Kolposcopy
4.9
22.3
76
171
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
216.6
20.7
21
*
J05AB11
ATC
valaciclovir; oral
3.4
20.2
108
364
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
19.9
19
*
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
+∞
19.9
19
*
K02.9
ICD-10 Finland
Dental caries, unspecified
9.8
19.9
40
43
TAB00
NOMESCO Finland
Lumbar puncture
5.6
19.8
59
114
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.6
19.6
58
111
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
19.3
87
255
J05AB01
ATC
aciclovir; systemic
2.6
18.8
159
718
Z01.2
ICD-10 Finland
Dental examination
2.2
18.7
292
1785
K02.2
ICD-10 Finland
Caries of cementum
6.0
18.5
52
93
C10AA07
ATC
rosuvastatin; oral
2.5
17.4
165
789
N05CF01
ATC
zopiclone; oral
2.3
17.4
204
1087
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
17.0
119
478
B90
ICPC
HIV-infection/AIDS
+∞
16.7
16
*
R50.9
ICD-10 Finland
Fever, unspecified
2.9
16.7
113
442
ZX114
NOMESCO Finland
Intramuscular
9.6
16.3
33
36
Y25
ICPC
Fear sexually transm disease male
5.5
15.9
47
90
N05CD07
ATC
temazepam; oral
3.3
15.8
84
280
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.1
15.8
63
166
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.6
15.7
126
547
B02.9
ICD-10 Finland
Zoster without complication
5.5
15.4
46
89
R4110
NOMESCO Finland
Physiotherapy
2.2
15.3
182
967
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
29.4
15.3
20
7
S02.51
ICD-10 Finland
Fracture of tooth, open
3.1
14.9
89
321
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
14.6
46
95
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
27.9
14.3
19
7
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
27.9
14.3
19
7
WX110
SPAT
NA
4.3
14.3
54
135
SPAT1263
SPAT
Sampling
0.4
13.9
85
1692
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
11.8
13.9
25
22
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.5
13.9
41
79
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
13.6
13
*
EB1AA
SPAT
NA
4.0
13.6
55
147
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.6
13.0
105
455
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.3
12.9
28
35
R74
ICPC
Upper respiratory infection acute
2.0
12.9
201
1181
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
12.8
39
1037
SPAT1301
SPAT
No procedures
0.3
12.8
41
1060
UJF30
NOMESCO Finland
Ileoscopy through colon
3.0
12.7
78
287
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
12.5
99
425
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
12.2
124
604
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
12.2
128
633
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
11.5
11
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
11.5
11
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
11.5
11
*
J01MA12
ATC
levofloxacin; systemic
2.3
11.5
117
568
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
122.1
11.5
12
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
11.4
59
193
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
11.2
50
146
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
6.6
11.2
28
44
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
11.0
93
412
M01AC06
ATC
meloxicam; systemic, rectal
0.5
11.0
81
1530
SPAT1153
SPAT
Removal of sutures
0.4
10.9
47
1081
D11
ICPC
Diarrhoea
2.5
10.8
89
388
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
10.6
167
974
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
10.5
39
97
B17.1
ICD-10 Finland
Acute hepatitis C
111.7
10.4
11
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
10.4
10
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
12.3
10.4
18
15
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
11.5
10.1
18
16
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.5
9.9
87
1563
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
12.4
9.9
17
14
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
26.5
9.8
13
5
Z71.8
ICD-10 Finland
Other specified counselling
1.9
9.8
153
888
UJH02
NOMESCO Finland
Anoscopy
4.1
9.8
37
94
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.4
9.5
86
394
Z30.2
ICD-10 Finland
Sterilization
0.2
9.5
9
442
A01AB04
ATC
amphotericin B; local oral
4.4
9.4
33
78
C10AA01
ATC
simvastatin; oral
0.5
9.4
64
1251
5AB01
NOMESCO Finland
NA
+∞
9.4
9
*
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
9.4
9
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.7
9.3
18
19
J01MA02
ATC
ciprofloxacin; systemic
1.8
9.3
226
1517
-1
NOMESCO Finland
NA
1.7
9.2
224
1505
N06AB04
ATC
citalopram; systemic
2.0
9.0
128
717
WNF00
NOMESCO Finland
Infection source and contact determination
24.4
8.9
12
5
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.9
8.9
55
202
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.9
8.8
140
815
KMAK
NOMESCO Finland
NA
1.6
8.7
361
2808
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.8
8.6
15
13
WX290
SPAT
NA
4.0
8.6
33
86
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
20.3
8.5
12
6
JN4BD
NOMESCO Finland
Extensive body CT
2.6
8.4
63
262
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
8.3
8
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
8.3
8
*
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
8.3
85
1468
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
8.3
68
296
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
8.2
96
495
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
8.0
38
849
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
7.9
38
119
N05BA01
ATC
diazepam; systemic, rectal
2.1
7.7
86
433
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
45.5
7.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
12.0
7.6
13
11
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.4
7.5
66
297
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.2
7.5
10
406
N05BA04
ATC
oxazepam; oral
1.8
7.5
138
842
B59
ICD-10 Finland
Pneumocystosis
81.0
7.4
8
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
7.4
34
104
SPAT1097
SPAT
Recording of ECG
0.2
7.4
10
401
D06BB04
ATC
podophyllotoxin; topical
2.5
7.3
54
223
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
7.3
7
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
7.3
7
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
7.3
7
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
7.3
7
*
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
7.3
7
*
D07AB08
ATC
desonide; topical
2.2
7.1
73
354
XA800
NOMESCO Finland
Neuropsychological investigation
3.2
7.1
35
113
SPAT1312
SPAT
General health counselling
0.5
7.0
61
1109
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.0
205
1433
ZXA05
NOMESCO Finland
Left side
1.8
6.9
136
843
SPAT1310
SPAT
Counselling related to known health issue
0.5
6.9
60
1096
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
8.4
6.9
14
17
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.8
6.8
27
73
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
22.8
6.7
9
*
M01AH05
ATC
etoricoxib; oral
0.6
6.6
240
3088
J20
ICD-10 Finland
Acute bronchitis
2.4
6.6
55
243
ZXA00
NOMESCO Finland
Right side
1.7
6.5
142
910
KFD46
NOMESCO Finland
Bilateral vasectomy or ligature of vas deferens
0.1
6.5
*
220
D06BB10
ATC
imiquimod; topical
3.4
6.5
29
87
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
6.5
15
459
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
4.0
6.4
24
62
A52.9
ICD-10 Finland
Late syphilis, unspecified
70.5
6.4
7
*
T40.1
ICD-10 Finland
Poisoning: Heroin
70.5
6.4
7
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
6.4
34
116
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
6.4
41
156
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
6.4
61
287
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
6.3
32
106
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
6.3
53
235
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
6.3
6
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
6.3
6
*
Y71
ICPC
Gonorrhoea male
+∞
6.3
6
*
OAB43
SPAT
NA
0.5
6.3
51
952
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
26.9
6.2
8
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
6.2
67
333
D82
ICPC
Teeth/gum disease
0.6
6.2
101
1554
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
6.2
45
187
D01AE16
ATC
amorolfine; topical
2.1
6.2
65
322
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.6
6.2
43
172
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
7.8
6.1
13
17
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.3
6.1
13
410
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.1
64
1107
N06AX11
ATC
mirtazapine; oral
1.6
6.0
180
1257
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011397) Hemoglobin [Presence] in Urine by Test strip
545
1126
17.15
309.41
3.5
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
640
812
66.61
307.65
5.6
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
607
44
907.69
307.65
3.0
2.0
%
30.0
44.6
—
29
9
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
503
520
30.25
307.65
2.5
3.0
u/l
27.7
130.4
0.61
498
462
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
565
27
993.70
307.65
3.1
2.6
%
31.1
39.8
—
97
10
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
506
47
365.89
307.65
2.6
2.3
e6/l
742.5
717.0
0.10
37
27
(3021879) Hepatitis B virus core Ab [Presence] in Serum
579
519
54.39
307.65
5.0
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
660
19
4503.79
307.65
16.0
1.2
u/ml
2833.0
—
—
413
0
(3037121) Protein [Mass/volume] in Urine
619
152
296.86
307.65
7.5
3.7
g/l
0.1
0.3
3.40
600
70
(40758558) Short blood count panel - Blood
586
1335
19.79
307.18
13.3
7.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
663
1852
36.47
290.76
13.7
6.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
605
1717
17.40
250.12
4.8
3.5
e6/l
29.6
87.6
1.25
284
1228
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
115
14
97.70
220.32
3.3
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
539
1492
11.61
219.99
1.9
1.7
mmol/l
1.4
1.6
2.13
533
1289
(3019832) Treponema pallidum Ab [Presence] in Serum
326
547
10.12
206.69
2.9
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
680
2570
34.62
204.80
18.4
6.5
%
0.8
0.7
5.83
680
2446
(3006504) Eosinophils/100 leukocytes in Blood
681
2652
33.97
196.54
18.4
6.4
%
2.9
2.9
0.18
681
2521
(3019069) Monocytes/100 leukocytes in Blood
682
2671
34.66
195.39
18.4
6.7
%
8.9
8.8
0.93
682
2553
(3018010) Neutrophils/100 leukocytes in Blood
682
2721
33.64
190.04
18.2
6.2
%
50.2
57.0
58.08
682
2601
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
167
120
17.85
188.89
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
682
2753
33.01
186.70
18.4
6.4
%
36.2
28.1
81.92
682
2626
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
139
70
24.41
185.99
1.1
1.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
690
2835
42.01
185.53
18.3
6.2
e9/l
0.5
0.6
11.61
680
2500
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
685
2791
35.66
185.50
10.6
7.0
umol/l
11.6
11.8
0.35
680
2671
(3006315) Basophils [#/volume] in Blood
690
2841
41.86
184.93
18.2
6.3
e9/l
0.0
0.0
0.28
680
2505
(3021589) Normoblasts [#/volume] in Blood
645
2472
17.44
183.67
18.4
9.2
e9/l
0.0
0.0
0.65
628
2039
(3016650) Hepatitis A virus Ab [Presence] in Serum
167
129
16.59
181.29
1.1
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
691
2929
41.49
177.20
18.2
6.4
e9/l
2.2
1.9
11.56
680
2621
(3013115) Eosinophils [#/volume] in Blood
691
2930
41.47
177.11
18.5
6.7
e9/l
0.2
0.2
3.89
681
2622
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
208
260
10.87
163.97
5.8
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
691
3217
35.20
151.69
19.4
9.8
e9/l
3.1
4.1
54.49
681
2833
(3021601) Nitrite [Presence] in Urine by Test strip
622
2596
11.73
151.06
7.1
4.1
estimate
0.0
0.0
0.50
51
490
(3035350) Ketones [Presence] in Urine by Test strip
622
2596
11.73
151.06
4.0
2.9
estimate
0.0
0.0
0.00
51
470
(3009261) Glucose [Presence] in Urine by Test strip
623
2614
11.75
150.13
4.0
3.0
estimate
0.0
0.0
0.00
47
442
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
216
324
9.12
146.18
5.8
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
105
49
24.94
144.04
2.8
1.8
—
—
—
0
0
(3013762) Body weight Measured
127
0
+∞
136.99
1.2
0.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
83
25
37.43
131.80
3.9
2.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
160
199
10.07
124.90
2.9
3.2
mg/l
1.2
1.4
2.79
152
188
(3037467) Urinalysis macro (dipstick) panel - Urine
681
3603
19.72
115.56
8.5
3.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
89
47
21.49
115.42
3.7
2.1
%
10.7
14.0
—
6
21
(3011412) CD3 cells [#/volume] in Blood
97
65
17.11
112.19
5.4
2.4
e9/l
1.5
1.1
1.65
58
30
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
148
193
9.41
110.77
1.2
1.3
miu/ml
172.1
233.4
0.82
52
89
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
70
41
18.82
86.14
5.4
2.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
55
17
34.97
86.09
5.2
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
365
1363
4.43
85.22
3.0
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
364
1375
4.36
83.23
3.1
2.9
e6/l
0.2
0.4
1.16
269
1018
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
256
743
4.81
83.09
4.2
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
270
823
4.66
82.20
4.7
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
373
1494
4.13
77.25
3.1
3.0
e6/l
34.1
90.7
0.67
280
1142
(3052851) Hemolysis interference index of Serum or Plasma
103
136
8.68
75.34
2.3
3.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
51
27
20.26
65.45
5.4
2.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
75
81
10.23
63.85
2.1
2.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
62
51
13.22
63.24
4.7
2.4
e6/l
969.8
746.1
0.57
52
42
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
73
79
10.18
62.02
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
236
793
3.95
60.52
2.6
2.7
e6/l
2.0
1.2
0.47
108
416
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
386
1810
3.46
58.65
3.3
3.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
58
52
12.05
55.96
2.1
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
239
849
3.73
55.91
2.6
2.6
e6/l
1.1
1.0
0.08
111
471
(3009871) Measles virus Ab [Titer] in Serum
39
24
17.13
46.42
1.3
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
104
226
5.21
46.15
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
239
971
3.20
43.62
1.5
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
95
201
5.30
43.38
1.2
1.7
iu/ml
0.2
0.3
0.10
54
37
(3002385) Erythrocyte distribution width [Ratio]
674
5007
7.04
42.32
27.3
15.0
%
13.3
13.5
4.56
674
4918
(3003327) Ova and parasites identified in Stool by Light microscopy
86
184
5.18
38.66
2.5
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
225
940
3.03
38.45
2.6
2.6
mosm/kgh2o
636.0
591.2
2.04
199
811
(3000850) Epithelial cells [#/volume] in Urine
226
995
2.86
34.59
2.6
2.5
e6/l
3.6
4.8
0.64
205
883
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
24
12
20.66
31.17
1.2
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
568
4060
2.94
30.89
4.7
3.8
mm/h
11.0
9.3
2.08
560
3833
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
690
5580
7.77
30.68
21.6
10.9
ml/min/173m2
88.1
88.7
0.40
662
4650
(3016244) Insulin [Units/volume] in Serum or Plasma
35
38
9.63
29.36
6.7
3.2
mu/l
46.3
24.5
2.19
35
38
(1761868) Lipid panel - Serum or Plasma
120
2730
0.33
28.93
3.8
2.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
76
190
4.36
28.07
1.4
1.8
g/l
1.2
1.5
2.75
66
173
(3001964) Herpes simplex virus Ag [Presence] in Specimen
20
10
20.55
25.86
1.2
3.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
95
5.58
25.48
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
95
5.58
25.48
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
201
970
2.49
24.43
1.4
1.5
nmol/l
18.4
20.0
1.23
192
854
(3012898) Urea [Moles/volume] in Urine
27
5
56.00
23.20
1.5
1.8
mmol/l
229.3
152.0
—
27
5
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
15
14.39
22.86
2.1
1.7
iu/ml
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
56
136
4.38
21.39
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
112
430
2.90
21.25
2.1
2.4
ml/min/173m2
77.5
73.1
0.71
58
165
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
35
58
6.29
20.47
4.3
3.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
649
5421
3.14
18.79
28.3
14.9
g/l
336.6
335.2
3.54
649
5395
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
29
46
6.53
17.67
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
29
46
6.53
17.67
1.1
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
680
5886
4.17
17.57
14.4
12.4
mg/l
23.2
23.1
0.02
519
4591
(3009508) Creatinine [Moles/volume] in Urine
271
1660
2.02
17.30
4.3
3.4
mmol/l
9.0
9.0
0.02
255
1434
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
50
6.00
16.30
1.1
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
23
8.92
15.96
1.0
1.2
umol/l
30.6
25.6
1.46
20
23
(3009542) Hematocrit [Volume Fraction] of Blood
670
5832
3.36
15.35
27.8
12.6
%
42.2
41.9
0.88
622
4768
(40761511) CBC panel - Blood by Automated count
551
6279
0.47
15.09
10.3
11.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
221
1391
1.85
12.18
3.1
4.2
ph
7.4
7.4
0.05
19
259
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
50
172
3.05
11.42
2.6
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
51
178
3.01
11.36
1.7
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
73
309
2.52
11.26
1.7
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
178
1070
1.88
11.21
2.1
2.1
mg/l
2.6
2.9
0.94
154
943
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
264
1796
1.75
10.98
1.8
1.8
pmol/l
95.3
95.6
0.04
150
1027
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
106
535
2.15
10.89
1.6
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
105
544
2.09
10.06
1.6
1.9
—
—
—
0
0
(3013512) EKG study
69
1381
0.45
9.54
2.7
3.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
19
37
5.25
9.40
1.0
1.1
nmol/l
149.3
153.4
0.13
19
37
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
152
2.95
9.38
1.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
885
0.33
9.29
1.4
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
43
1032
0.38
9.23
1.3
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
148
2.95
9.22
2.3
7.9
iu/ml
7539.4
258.6
—
5
24
(3030905) Polymorphonuclear cells [#/volume] in Blood
35
111
3.26
9.16
3.9
3.8
e9/l
2.9
4.3
6.77
35
111
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
107
3.29
9.01
2.2
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
7
18.88
8.96
4.0
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
113
3.21
8.91
4.0
4.4
%
48.9
56.4
3.61
35
113
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
344
2.25
8.85
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
92
482
2.04
8.52
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
178
2.69
8.51
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
130
2048
0.55
8.48
2.8
3.1
ng/l
21.0
39.5
1.94
63
1277
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
383
4626
0.63
8.34
3.8
3.3
u/l
57.5
52.3
0.56
363
4425
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
60
267
2.36
8.31
1.5
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
92
488
2.02
8.23
2.7
2.8
%
1.7
1.7
0.31
87
450
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
45
178
2.63
7.99
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
120
706
1.84
7.87
1.6
2.5
g/l
2.5
2.4
1.80
115
664
(3024891) Influenza virus A+B Ag [Presence] in Specimen
46
187
2.56
7.73
1.1
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
8
15.22
7.73
4.9
2.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
492
1.97
7.71
1.9
2.5
g/l
0.2
0.2
1.50
85
458
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
113
662
1.84
7.50
1.7
2.6
%
21.1
25.3
2.32
107
587
(3023368) Bacteria identified in Blood by Culture
198
1370
1.62
7.16
5.0
4.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
252
2.28
7.14
5.4
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
602
0.30
7.12
5.9
6.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
41
166
2.56
6.97
3.2
3.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
62
3.63
6.91
2.0
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
184
1283
1.58
6.35
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
145
2075
0.62
6.04
4.9
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
112
699
1.71
5.96
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
591
0.35
5.93
1.1
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
161
2.44
5.90
1.2
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
81
466
1.83
5.68
2.6
3.5
mmol/l
0.4
1.9
2.54
63
376
(3012516) Albumin [Mass/volume] in Urine
200
1456
1.52
5.61
2.9
3.4
mg/l
382.9
277.8
0.13
147
1005
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
42
3.87
5.56
2.8
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
277
2162
1.46
5.47
6.2
7.0
mmol/l
1.2
1.2
0.12
266
2000
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
106
670
1.68
5.37
2.3
3.2
umol/l
9.3
8.8
0.10
92
600
(3023520) Reticulocytes [#/volume] in Blood
64
348
1.92
5.34
1.6
2.9
e9/l
62.5
73.3
1.63
33
263
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
316
1.95
5.15
2.1
4.3
ng/l
73.7
87.6
1.06
59
291
(3051651) Icteric interference index of Serum or Plasma
14
36
3.95
5.00
3.2
4.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
60
327
1.91
4.99
1.3
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
116
766
1.61
4.95
1.6
1.9
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
18
56
3.27
4.92
1.1
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
703
6772
3.27
4.47
29.7
17.5
pg
31.4
30.4
37.26
703
6706
(3044290) Cell count panel - Cerebral spinal fluid
29
124
2.40
4.47
1.8
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
703
6773
3.26
4.45
29.8
17.5
fl
93.1
90.3
41.76
703
6708
(3000963) Hemoglobin [Mass/volume] in Blood
703
6776
3.23
4.39
30.0
17.7
g/l
142.7
142.3
0.27
703
6706
(3007853) Bacteria identified in Skin by Aerobe culture
98
640
1.62
4.37
1.9
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
140
994
1.51
4.32
3.1
3.7
ng/l
77.0
642.2
3.72
99
738
(3019225) pH of Specimen
17
442
0.37
4.30
4.9
4.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
62
359
1.80
4.29
3.3
2.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
9
8.97
4.29
1.1
3.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
75
459
1.71
4.28
12.7
10.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
174
2254
0.70
4.06
2.8
3.2
%
24.1
21.4
0.67
62
808
(3019060) Gas panel - Arterial blood
11
343
0.31
4.04
3.1
6.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
64
381
1.75
4.04
3.3
2.4
—
—
—
0
0
(3020891) Body temperature
5
209
0.23
4.03
3.2
4.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
64
382
1.74
4.00
3.3
2.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
48
3.17
3.95
1.7
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
34
165
2.11
3.93
2.4
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
156
1155
1.45
3.88
1.4
1.4
g/l
3.2
2.5
1.53
69
795
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
54
3.01
3.87
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
64
386
1.72
3.87
3.3
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
64
387
1.72
3.83
3.3
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
44
3.23
3.79
3.4
4.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
102
2.40
3.78
2.0
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
231
2828
0.73
3.75
3.5
3.5
ug/l
2.0
1.8
0.30
214
2616
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
289
2388
1.35
3.73
6.1
7.6
mmol/l
1.2
1.2
0.38
261
2062
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
35
178
2.02
3.59
2.0
2.9
%
210.1
188.0
0.58
35
173
(3000093) Morphology [Interpretation] in Blood Narrative
13
41
3.21
3.51
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
6
10.07
3.50
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
74
477
1.62
3.49
1.6
2.4
g/l
12.4
10.5
2.13
65
440
(1001926) Buprenorphine [Presence] in Urine by Screen method
52
307
1.75
3.41
3.1
2.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
14
5.77
3.35
1.0
1.9
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
11
32
3.48
3.34
1.0
1.0
iu/ml
12.2
6.0
—
5
10
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
128
2.15
3.34
1.8
1.3
e6/l
17.0
14.5
0.08
21
95
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
128
2.15
3.34
1.8
1.4
e6/l
1109.6
2005.3
0.23
22
100
(4094501)
6
201
0.29
3.26
1.2
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
11
6.41
3.19
1.1
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
73
2.50
3.15
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
65
417
1.61
3.14
4.7
4.5
%
0.3
0.5
—
9
107
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
39
3.11
3.10
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
297
0.36
3.07
2.0
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
8
7.55
3.06
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
370
0.45
2.87
1.2
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
271
0.36
2.83
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
116
1527
0.71
2.82
4.8
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
65
429
1.57
2.81
5.0
4.8
%
0.0
0.2
—
10
129
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
239
1988
1.30
2.77
2.2
2.3
nmol/l
72.7
72.6
0.01
231
1840
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
202
2441
0.76
2.77
3.3
3.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
91
2.23
2.76
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
91
2.23
2.76
1.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
145
1124
1.36
2.72
1.6
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
62
409
1.56
2.70
5.1
4.9
%
0.0
0.1
—
9
113
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
113
2.07
2.64
2.1
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
108
802
1.41
2.62
1.3
1.3
titre
324.0
359.2
0.14
20
149
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
121
2.02
2.58
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
94
2.16
2.57
1.5
1.5
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
11
5.49
2.55
1.0
1.0
mg/g
11.4
6.2
—
6
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
165
1.85
2.53
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
57
376
1.56
2.49
1.5
1.8
g/l
1.5
1.3
0.24
50
352
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
12
5.03
2.40
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
77
2.24
2.39
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
124
1577
0.74
2.39
2.1
2.5
umol/l
5883.9
4401.8
0.15
107
1434
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
481
4415
1.27
2.38
3.6
3.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
22
3.67
2.37
1.0
1.6
u/l
15.1
14.5
—
8
22
(3017181) Myelocytes/100 leukocytes in Blood
66
457
1.49
2.33
4.9
4.7
%
0.4
0.9
—
10
142
(3016018) Differential panel - Cerebral spinal fluid
15
65
2.34
2.33
2.4
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
35
2.88
2.31
1.0
1.1
iu/ml
720.0
187.7
—
10
35
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
71
500
1.47
2.31
2.9
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
106
804
1.37
2.28
2.1
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
47
2.58
2.28
1.5
3.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
13
4.64
2.27
3.5
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
13
4.64
2.27
1.2
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
27
149
1.84
2.27
1.1
1.3
mg/l
500.5
507.5
0.04
27
142
(40760892) CBC W Ordered Manual Differential panel - Blood
108
1392
0.74
2.27
6.9
4.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
153
1228
1.31
2.26
1.3
1.2
u/ml
2.3
2.0
0.08
16
370
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
48
2.53
2.19
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
37
227
1.66
2.19
2.0
2.4
s
22.3
21.8
0.26
37
197
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
69
948
0.70
2.14
1.3
1.2
iu/ml
22.0
27.3
0.19
18
295
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
236
0.42
2.12
2.7
3.2
mmol/l
25.0
24.8
—
10
231
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
102
1.99
2.12
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
95
1236
0.73
2.12
2.7
3.1
ng/l
943.5
1017.1
0.13
84
1029
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
146
1.81
2.09
1.0
1.2
u/ml
354.7
236.5
0.71
16
97
(3021788) Differential panel - Synovial fluid
17
82
2.10
2.08
1.4
1.5
—
—
—
0
0
(4034850)
8
190
0.41
2.08
3.9
9.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
31
2.93
2.08
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
76
2.13
2.03
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
193
1.69
2.03
1.7
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
281
1.56
2.00
17.7
14.6
mmol/l
24.1
24.5
0.47
37
269
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
156
1.76
1.99
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
105
1331
0.75
1.96
5.3
3.2
estimate
0.0
0.0
0.80
52
463
(3019309) Folate [Moles/volume] in Red Blood Cells
94
718
1.36
1.95
1.8
1.6
nmol/l
837.5
1191.8
4.70
84
571
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
27
444
0.59
1.95
1.7
2.1
ug/l
8.7
9.4
0.06
21
413
(3008898) HLA-B27 [Presence]
14
280
0.49
1.94
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
50
0.00
1.89
0.0
7.3
—
7.2
—
0
45
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
65
2.18
1.89
1.7
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
109
1.86
1.79
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
109
1.86
1.79
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
24
2.93
1.72
1.1
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
24
2.93
1.72
1.1
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
252
2210
1.22
1.72
2.5
2.7
ug/l
185.0
152.2
0.39
242
2099
(4035726)
56
402
1.43
1.69
1.2
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
55
2.20
1.68
1.2
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
119
1.79
1.68
2.5
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
70
919
0.74
1.66
1.5
1.6
pmol/l
426.1
32590267.2
0.97
62
807
(3004588) Protein electrophoresis panel - Serum or Plasma
42
288
1.49
1.61
1.6
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
89
697
1.32
1.59
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
26
2.71
1.58
3.7
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
114
1.78
1.58
1.5
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
60
443
1.39
1.56
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
179
1532
1.22
1.54
3.5
4.1
mg/mmol
14.5
9.5
0.56
130
1044
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
43
0.00
1.52
0.0
1.3
—
1.1
—
0
17
(3022313) Gas panel - Capillary blood
14
256
0.54
1.52
2.1
3.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
21
2.87
1.51
1.2
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
45
0.00
1.50
0.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
49
666
0.72
1.46
1.2
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
18
102
1.78
1.46
2.9
4.0
u/ml
12.0
121.5
0.45
18
97
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
172
1.59
1.45
1.4
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
39
2.32
1.43
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
118
1.71
1.42
1.5
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
228
2014
1.19
1.40
2.1
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
21
127
1.67
1.38
1.1
2.3
—
1.2
—
0
13
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
23
2.62
1.37
1.2
5.0
mg/l
63.5
79.8
—
6
16
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
151
1.61
1.36
2.2
3.4
u/ml
0.5
0.3
—
9
85
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
38
0.00
1.34
0.0
1.3
—
27.6
—
0
28
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
38
0.00
1.34
0.0
1.1
—
100.5
—
0
30
(4027681)
9
42
2.16
1.34
1.2
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
39
275
1.44
1.34
1.1
1.1
—
75.1
—
0
8
(3027315) Oxygen [Partial pressure] in Blood
19
113
1.70
1.33
2.7
4.1
kpa
9.7
9.0
1.71
19
113
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
69
876
0.76
1.32
1.3
1.2
u/ml
16.8
8.7
0.25
16
367
(3037756) Immunofixation for Serum or Plasma
15
83
1.82
1.32
1.2
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
114
1.68
1.29
2.7
4.1
mmol/l
1.3
2.7
—
8
76
(3013290) Carbon dioxide [Partial pressure] in Blood
19
114
1.68
1.29
2.7
4.1
kpa
4.7
5.0
2.02
19
114
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
148
1713
0.83
1.25
4.5
2.9
u/l
68.0
57.5
2.65
143
1621
(3002256) Pathology report gross observation
76
606
1.28
1.22
1.3
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
37
265
1.42
1.19
1.2
1.5
—
13.8
—
0
12
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
26
2.32
1.19
1.2
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
183
1608
1.19
1.18
2.2
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
94
1.72
1.18
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
150
1.55
1.15
1.8
2.5
ug/min
163.6
150.2
0.06
16
82
(3028433) Virus identified in Specimen by Culture
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
200
1.47
1.14
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
143
1646
0.84
1.13
1.3
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
30
2.35
1.12
1.0
1.0
miu/ml
1932.6
1466.4
—
7
30
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
30
2.35
1.12
1.0
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
7
31
2.27
1.10
2.7
2.1
—
411.8
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
31
2.27
1.10
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
610
5911
1.22
1.09
15.2
13.9
mmol/l
3.9
4.0
8.25
596
5778
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
228
1.42
1.07
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
940
1.21
1.07
2.3
2.4
nmol/l
16.9
14.3
2.86
103
867
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
145
1261
1.19
1.06
1.8
1.8
mg/l
2.1
1.0
0.46
111
949
(3029075) Extractable nuclear Ab panel - Serum
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
345
0.69
1.03
2.1
3.2
kpa
4.8
5.2
2.78
24
323
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
177
0.56
1.03
1.5
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
68
1.78
1.01
1.1
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
48
1.89
1.00
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
48
1.89
1.00
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
131
0.53
0.99
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
23
2.18
0.98
1.0
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
29
0.00
0.98
0.0
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
398
0.72
0.97
1.9
2.9
e9/l
3.7
4.1
0.54
24
335
(1002224) Polysomnography panel
30
409
0.72
0.97
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
24
340
0.70
0.96
2.1
3.2
ph
7.4
7.4
—
6
44
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
377
3998
0.88
0.96
2.6
3.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
185
0.59
0.95
1.5
1.8
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
7
37
1.90
0.94
1.0
1.8
mg/l
3.6
3.8
—
7
37
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
101
1.60
0.94
1.2
1.1
—
11.4
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
52
1.74
0.92
1.1
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
325
0.70
0.92
2.1
3.3
mmol/l
0.2
1.5
2.02
13
241
(40761535) Cells panel - Urine sediment
28
382
0.72
0.91
3.3
3.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
115
994
1.19
0.91
2.9
2.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
63
1.76
0.90
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
101
0.49
0.90
1.2
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
79
1.66
0.88
1.7
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
17
111
1.54
0.88
1.5
1.6
e6/l
12574.6
14584.9
—
8
82
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
216
0.64
0.87
1.7
1.2
—
1.6
—
0
19
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
151
1688
0.87
0.84
2.3
2.4
ug/l
0.7
0.7
0.07
111
886
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
24
0.00
0.79
0.0
3.0
—
60.6
—
0
24
(3020650) Glucose [Presence] in Urine
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
103
895
1.18
0.78
2.5
4.0
mmol/l
0.8
0.8
0.03
92
855
(3013139) Helicobacter pylori Ag [Presence] in Stool
43
341
1.28
0.78
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
186
0.64
0.77
1.1
2.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
27
0.00
0.77
0.0
2.9
—
37.1
—
0
7
(3045716) Anion gap in Serum or Plasma
0
27
0.00
0.77
0.0
1.7
—
9.4
—
0
20
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
18
256
0.70
0.77
1.8
2.4
%
0.6
0.7
0.42
18
250
(40768446) Kidney Pathology biopsy report
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
28
0.00
0.76
0.0
1.2
—
6.6
—
0
28
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
54
1.68
0.74
3.1
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.0
2.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
603
5883
1.16
0.73
14.5
13.9
mmol/l
139.2
139.7
6.61
591
5753
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
68
1.63
0.72
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
41
1.71
0.70
1.0
2.5
—
—
—
0
0
(4010399)
30
384
0.77
0.68
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
667
0.83
0.68
1.6
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
70
1.58
0.65
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
136
1226
1.13
0.65
2.3
2.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3010421) pH of Blood
19
138
1.39
0.63
2.7
3.9
ph
7.4
7.4
0.03
19
114
(1761482) Bacteria [#/volume] in Urine by Culture
6
103
0.58
0.62
3.3
3.8
—
—
—
0
0
(3000492) Spirometry study
66
766
0.85
0.61
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
50
1.61
0.61
1.0
1.2
—
—
—
0
0
(4198724)
8
51
1.57
0.60
1.8
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
20
0.00
0.60
0.0
7.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
105
1.44
0.60
1.5
1.3
u/ml
1.3
4.3
—
8
34
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.1
—
9.5
—
0
21
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
100
1121
0.87
0.59
5.1
3.2
kg/l
1.0
1.0
—
7
129
(3017569) Oxygen content in Arterial blood
0
22
0.00
0.59
0.0
4.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
6.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
23
0.00
0.58
0.0
1.2
—
9.3
—
0
23
(3022621) pH of Urine by Test strip
21
275
0.76
0.58
2.8
2.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
35
1.72
0.57
1.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
81
1.49
0.57
2.0
2.8
—
—
—
0
0
(4268621)
11
73
1.51
0.56
3.0
2.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
160
0.68
0.56
2.5
2.8
u/l
6859.6
544.3
—
5
54
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
762
1.15
0.54
3.3
3.2
mmol/l
2.4
2.4
0.11
69
680
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.0
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
64
1.41
0.51
3.3
3.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.5
u/l
5.1
8.4
—
6
33
(3045424) Erythrocytes [Presence] in Urine
7
107
0.65
0.49
1.4
1.3
—
—
—
0
0
(44806118)
10
68
1.48
0.47
1.0
2.0
—
—
—
0
0
(44790049)
10
68
1.48
0.47
1.0
2.0
—
—
—
0
0
(44790047)
10
68
1.48
0.47
1.0
2.0
—
—
—
0
0
(44790048)
10
68
1.48
0.47
1.0
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
85
1.42
0.47
1.2
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
82
734
1.13
0.46
1.7
2.6
ug/g
159.2
125.8
0.32
65
619
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
237
1.23
0.46
1.2
1.4
iu/l
15.2
21.4
0.70
18
201
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
308
0.80
0.45
24.7
14.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
215
2027
1.09
0.45
5.3
7.7
inr
1.1
1.2
0.70
49
616
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
95
1.38
0.44
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
78
1.42
0.43
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
27
221
1.23
0.43
1.4
1.7
—
277.1
—
0
7
(3035320) C reactive protein [Mass/volume] in Body fluid
5
32
1.57
0.42
2.6
2.6
—
—
—
0
0
(3036603) Volume of Urine
5
32
1.57
0.42
1.8
1.7
—
1572.0
—
0
5
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
122
1126
1.10
0.41
2.1
2.1
%
1.6
1.5
1.58
106
1023
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
60
1.34
0.40
1.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
18
0.00
0.40
0.0
8.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
35
1.43
0.39
1.4
2.6
%
106.2
88.1
—
5
35
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
16.8
—
0
19
(3043410) Blood group antigens tested for on Red Blood Cells
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
159
0.75
0.38
1.2
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
247
0.80
0.38
2.1
2.6
e6/l
0.1
0.1
0.69
20
239
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
67
1.35
0.38
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
68
1.33
0.37
1.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
68
1.33
0.37
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
69
763
0.89
0.36
1.5
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
100
1.31
0.33
1.9
2.8
kpa
9.4
8.3
1.20
13
93
(3015377) Calcium [Moles/volume] in Serum or Plasma
162
1531
1.08
0.33
4.9
3.5
mmol/l
2.4
2.3
0.60
144
1389
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
88
0.68
0.33
1.5
3.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
193
1.20
0.31
1.5
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
55
1.28
0.30
1.0
1.5
g/l
1.1
1.0
—
7
55
(3003396) Base excess in Arterial blood by calculation
55
601
0.91
0.25
14.7
10.8
mmol/l
-0.1
1.1
1.16
40
481
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.2
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
83
0.72
0.24
1.0
2.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
168
0.83
0.23
1.1
1.1
—
6.2
—
0
24
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
88
1.25
0.22
1.0
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
0.5
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
1.1
—
1.2
—
0
12
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
9.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
13
0.00
0.21
0.0
3.5
—
5992.6
—
0
13
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
13
0.00
0.21
0.0
1.2
—
1.2
—
0
13
(3022689) Creatine [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
48
1.25
0.20
1.7
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.8
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
108
1.21
0.20
1.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
108
1.21
0.20
1.2
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
113
0.79
0.20
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
31
279
1.12
0.19
1.4
1.4
u/l
11.0
6.4
0.72
20
234
(3027801) Oxygen [Partial pressure] in Arterial blood
56
599
0.93
0.18
15.3
10.8
kpa
12.1
12.5
0.24
50
576
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
56
599
0.93
0.18
15.3
10.8
kpa
5.1
5.1
0.15
50
573
(3042631) Mycobacterium sp identified in Specimen
5
67
0.74
0.17
2.0
3.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
68
1.18
0.16
1.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
71
1.13
0.16
1.8
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
323
1.09
0.15
1.1
1.2
iu/ml
160.4
135.1
—
7
120
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
83
1.09
0.14
1.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
93
1.19
0.14
1.1
2.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
16
141
1.14
0.14
1.5
2.2
u/ml
22.9
33.2
0.55
16
134
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
122
1.15
0.14
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
149
0.87
0.13
1.0
1.2
—
3.3
—
0
14
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
13
149
0.87
0.13
1.0
1.2
—
15.1
—
0
21
(3045414) Leukocytes [Presence] in Urine
19
211
0.90
0.13
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
200
0.90
0.12
3.4
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
27
292
0.92
0.12
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
405
4008
1.02
0.10
2.8
3.3
pmol/l
13.8
14.6
11.04
386
3723
(21494434) Karyotype in Bone marrow
5
45
1.11
0.10
1.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
174
1.09
0.09
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.2
2.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
58
1.03
0.08
2.0
2.7
umol/l
2.5
6.6
—
6
44
(4062490)
7
67
1.05
0.08
1.1
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
147
1.09
0.07
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
85
0.82
0.07
1.1
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
84
1.07
0.07
1.0
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
505
5023
1.02
0.06
3.8
3.9
mu/l
1.9
2.3
0.71
485
4706
(3003740) Influenza virus B Ag [Presence] in Specimen
16
148
1.08
0.06
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
129
1.09
0.05
1.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
131
0.91
0.05
1.1
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
129
1.09
0.05
1.1
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
109
0.92
0.04
1.0
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
128
0.94
0.02
1.3
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
114
1.05
0.00
1.0
1.2
—
1.0
—
0
8
(4306422)
12
114
1.05
0.00
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
15
156
0.96
0.00
1.0
1.2
—
29.8
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
295
1.02
0.00
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
113
0.97
0.00
1.3
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
434
0.99
0.00
7.2
3.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
44
436
1.01
0.00
2.3
2.3
—
21.8
—
0
37
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
222
0.99
0.00
2.0
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
258
1.01
0.00
1.6
1.6
mu/l
260.6
258.5
0.03
26
240
(40760888) Immunoglobulin light chains.free panel - Serum
10
99
1.01
0.00
1.2
2.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
12
119
1.01
0.00
1.0
1.2
—
43.0
—
0
9
(3050129) First trimester maternal screen panel - Serum or Plasma
13
131
0.99
0.00
1.2
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
2.0
—
0
9
(44806420)
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
53
0.94
0.00
1.6
1.2
mosm/kgh2o
279.2
284.1
—
5
38
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
2.8
—
0
9
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.6
—
0.4
—
0
8
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
17.0
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
110
1.00
0.00
1.3
1.2
%
119.6
115.1
0.21
11
101
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
45.2
—
0
5
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
70
1.00
0.00
1.9
3.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
2.2
—
0
5
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
193.7
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
100
1.00
0.00
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.2
2.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
435.6
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
7
0.00
0.00
0.0
4.6
—
212.9
—
0
7
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.5
—
0
6
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
13.6
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
4.6
—
6.3
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
7.1
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_HIV – Human immunodeficiency virus [HIV] disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).